Praxis Precision Medicines
Stock Forecast, Prediction & Price Target
Praxis Precision Medicines Financial Estimates
Praxis Precision Medicines Revenue Estimates
Praxis Precision Medicines EBITDA Estimates
Praxis Precision Medicines Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $2.44M 0% | Avg: $880.44K Low: $641.67K High: $1.11M avg. -64.01% | Avg: $62.09M Low: $27.87M High: $108.89M avg. 6953.10% | Avg: $163.36M Low: $73.32M High: $286.48M avg. 163.07% | Avg: $366.43M Low: $164.47M High: $642.60M avg. 124.30% |
Net Income
% change YoY
| $-166.87M N/A | $-213.07M -27.68% | $-123.27M 42.14% | Avg: $-185.97M Low: $-80.97M High: $-44.24M avg. -50.86% | Avg: $-164.72M Low: $-87.83M High: $12.46M avg. 11.42% | Avg: $-16.03M Low: $-31.74M High: $-4.54M avg. 90.26% | Avg: $35.98M Low: $10.20M High: $71.24M avg. 324.44% |
EBITDA
% change YoY
| $-167.33M N/A | $-214.98M -28.47% | $-125.94M 41.41% | Avg: $528.26K Low: $385.00K High: $671.52K avg. 100.41% | Avg: $37.25M Low: $16.72M High: $65.33M avg. 6953.10% | Avg: $98.01M Low: $43.99M High: $171.88M avg. 163.07% | Avg: $219.86M Low: $98.68M High: $385.56M avg. 124.30% |
EPS
% change YoY
| -$58.96 N/A | -$69.33 -17.58% | -$18.69 73.04% | Avg: -$9.53 Low: -$12.28 High: -$6.71 avg. 48.99% | Avg: -$7.04 Low: -$13.32 High: $1.89 avg. 26.18% | Avg: -$2.43 Low: -$4.81 High: -$0.69 avg. 65.45% | Avg: $5.46 Low: $1.55 High: $10.8 avg. 324.44% |
Operating Expenses
% change YoY
| $167.33M N/A | $214.98M 28.47% | $128.82M -40.07% | Avg: $3.73M Low: $2.71M High: $4.74M avg. -97.10% | Avg: $263.12M Low: $118.10M High: $461.42M avg. 6953.10% | Avg: $692.19M Low: $310.69M High: $1.21B avg. 163.07% | Avg: $1.55B Low: $696.91M High: $2.72B avg. 124.30% |
FAQ
What is Praxis Precision Medicines stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 93.81% in 2025-2028.
We have gathered data from 8 analysts. Their low estimate is -80.97M, average is -185.97M and high is -44.24M.
What is Praxis Precision Medicines stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 1794.11% in 2025-2028.
We have gathered data from 6 analysts. Their low revenue estimate is $641.67K, average is $880.44K and high is $1.11M.
What is Praxis Precision Medicines stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 116.26% in 2025-2028.
We have gathered data from 8 analysts. Their low earnings per share estimate is -$12.28, average is -$9.53 and high is $-6.71.
What is the best performing analyst?
In the last twelve months analysts have been covering Praxis Precision Medicines stock. The most successful analyst is Kambiz Yazdi.